During thoracoscopic lobectomies for lung cancer, nalbuphine treatment prior to the induction of anesthesia also provided a significant analgesic effect, reduced the incidence of adverse reactions, and alleviated postoperative inflammatory responses with a reduced serum level of TNF-α [152]. Here, TNF is linked to lung cancer.